Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation
US12208087B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 2020 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Feb 25, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combination product comprising (i) nitazoxanide (NTZ) or an analogue thereof, and (ii) a PPAR agonist, for use in the treatment of an immune diseases or inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.